The US regulator has said that compounders can continue to trade in tirzepatide products while it undertakes a review to ...

Surging demand for weight loss drugs Wegovy and Zepbound from Novo Nordisk (NVO) and Eli Lilly (NYSE:LLY) has fueled concerns ...

PBMs are putting weight loss drugs, including Wegovy and Zepbound, on their national formularies, but coverage by plans is ...

The FDA updated its database of drugs in shortage to remove tirzepatide, which had sat on that list – along with related ...

There’s a war brewing over blockbuster weight loss medications — and patients are now getting caught in the crossfire.

Eli Lilly And Co. (NYSE:LLY) is ramping up its legal campaign against the compounding companies temporarily allowed to make ...

The market for injectable weight loss medications has experienced rapid growth. Goldman Sachs Research predicts the global ...

WW stock popped after announcing a new compounded semaglutide product to benefit from the current shortage of weight loss ...

Popular weight-loss medications including Ozempic and Wegovy contain a drug that seems to decrease cravings for food and ...

A CNBC investigation into counterfeit weight-loss drugs revealed an international illegal marketplace where criminals either alter the drugs or ship the real product from overseas.

The average workplace health insurance plan costs more than $25,000 amid rising prices and expensive weight-loss drugs such ...

Still, more than a quarter of employers are considering adding coverage for GLP-1 drugs for weight loss in 2025 or 2026, ...